Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy

Epilepsia

Volumn 54, Issue 6, 2013, Pages 1028-1035

  Brenner, Tanja ^a   Sills, Graeme J ^b,c   Hart, Yvonne ^a,d   Howell, Stephen ^e   Waters, Patrick ^a   Brodie, Martin J ^c   Vincent, Angela ^a   Lang, Bethan ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

^d NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Autoantibodies; Established epilepsy; Glutamic acid decarboxylase; Glycine receptor; Newly diagnosed epilepsy; NMDA receptor; Voltage gated potassium channel complex

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; GLYCINE RECEPTOR; MULTIPROTEIN COMPLEX; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ADOLESCENT; ADULT; AGED; ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CONTROL; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POTASSIUM CHANNELS, VOLTAGE-GATED; PREVALENCE; RADIOIMMUNOASSAY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; YOUNG ADULT;

EID: 84878598598     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12127     Document Type: Article

References (32)

1. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshé SL, Nordli D, Plouin P, Scheffer IE,. (2010) Revised terminology and concepts for organisation of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology. Epilepsia 51: 676-685.
2. Bien CG, Scheffer IE,. (2011) Autoantibodies and epilepsy. Epilepsia 52: 18-22.
3. Buckley C, Oger J, Clover L, Tüzün E, Carpenter K, Jackson M, Vincent A,. (2001) Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50: 73-78.
4. Errichiello L, Perruolo G, Pascarella A, Formisano P, Minetti C, Striano S, Zara F, Striano P,. (2009) Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol 211: 120-123.
5. Graus F, Saiz A, Dalmau J,. (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257: 509-517.
6. Haberlandt E, Bast T, Ebner A, Holthausen H, Kluger G, Kravljanac R, Kröll-Seger J, Kurlemann G, Makowski C, Rostasy K, Tuschen-Hofstätter Weber G, Vincent AC, Bien CG,. (2011) Limbic encephalitis in children and adolescents. Arch Dis Child 96: 186-191.
7. Hutchinson M, Waters P, McHugh J, Gorman G, O'Riordan S, Connolly S, Hager H, Yu P, Becker CM, Vincent A,. (2008) Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 71: 1291-1292.
8. Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR, Smith S,. (2008) Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71: 1647-1648.
9. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A,. (2010a) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133: 2734-2748.
10. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A,. (2010b) N-methyl- d -aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133: 1655-1667.
11. Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, Schott JM, Armstrong RJ, Zagami A, Bleasel A, Somerville ER, Smith SM, Vincent A,. (2011a) Fachiobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69: 892-900.
12. Irani S, Bien C, Lang B,. (2011b) Autoimmune epilepsies. Curr Opin Neurol 24: 146-153.
13. Kullmann DM,. (2010) Neurological channelopathies. Ann Rev Neurosci 33: 151-172.
14. Kwan P, Sills GJ, Kelly K, Butler E, Brodie MJ,. (2000) Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 42: 191-195.
15. Lalic T, Pettingill P, Vincent A, Capogna M,. (2011) Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission. Epilepsia 52: 121-131.
16. Lancaster E, Martinez-Hernandez E, Dalmau J,. (2011) Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 77: 179-189.
17. Liimatainen S, Peltola M, Sabater L, Fallah M, Kharazmi E, Haapala AM, Dastidar P, Knip M, Saiz A, Peltola J,. (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51: 760-767.
18. Majoie M, de Baets M, Renier W, Lang B, Vincent A,. (2006) Antibodies to voltage-gated potassium channels in epilepsy. Epilepsy Res 71: 135-141.
19. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG,. (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67: 470-478.
20. McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, Shoenfeld Y, Vincent A, Palace J, Lang B,. (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65: 1730-1736.
21. Niehusmann P, Dalmau J, Rudlowski C, Vincent A, Elger CE, Rossi JE, Bien CG,. (2009) Diagnostic value of N-methyl- d -aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 66: 458-464.
22. Palace J, Lang B,. (2000) Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 69: 711-714.
23. Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Keränen T, Graus F,. (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55: 46-50.
24. Quek AML, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein CJ, Watson RE, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA, Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ,. (2012) Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 69: 582-593.
25. Rees MI,. (2010) The genetics of epilepsy-the past, the present and future. Seizure 19: 680-683.
26. Sills GJ, Leach JP, Wilson EA, Parker P, Kelly K, Hamill I, Yule S, Greene J, Duncan R, Brodie MJ,. (2009) Titration influences initial efficacy of monotherapy in newly-diagnosed epilepsy. Epilepsia 50 (Suppl. 4): 70 (abstract).
27. Suleiman J, Brenner T, Gill D, Brilot F, Antony J, Vincent A, Lang B, Dale RC,. (2011) VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 76: 1252-1255.
28. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S,. (2004) Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62: 1177-1182.
29. Vincent A, Crino PB,. (2011) Systemic and neurologic autoimmune disorders associated with seizures or epilepsy. Epilepsia 52: 12-17.
30. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J,. (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy- responsive form of limbic encephalitis. Brain 127: 701-712.
31. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, Geraldes R, Vale T, Jacob A, Palace J, Maxwell S, Beeson D, Vincent A,. (2008) Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 65: 913-919.
32. Watson R, Jiang Y, Bermudez I, Houlihan L, Clover L, McKnight K, Cross JH, Hart IK, Roubertie A, Valmier J, Hart Y, Palace J, Beeson D, Vincent A, Lang B,. (2005) Antibodies to alpha7 nicotinic acetylcholine receptors in Rasmussen's encephalitis. Neurology 65: 1802-1805.